Indeed, the upregulation of NCX3 is auspicable in AD and the pharmacological stimulation of the activity of the NCX isoforms, such as NCX3, might be a promising valuable strategy to ameliorate the course of several neurological diseases, including AD [58]. This evidence concerns the gene TLX2 and nervous system disorder.